The US Federal Trade Commission (FTC) is suing Edwards Lifesciences to stop it from acquiring JenaValve, citing anticompetitive concerns.

Freenome has entered an exclusive licence agreement with Exact Sciences, granting the latter the rights to commercialise Freenome's blood-based CRC screening test in the US.

Medical Device Network sat down with Dexcom's outgoing CEO Kevin Sayer to learn more about how the company will maintain its market position and drive innovation in the CGM space in the future.

A key trend in the medical device market is smaller and smarter, which requires advanced materials and is the focus of the ...

HeartFlow is set to be listed on the Nasdaq under the symbol ‘HTFL’. Seeking a valuation of $1.46bn, the California-based company aims to raise $300m by offering 16.7 million shares priced between $17 ...